Literature DB >> 19544432

EpCAM is involved in maintenance of the murine embryonic stem cell phenotype.

Bárbara González1, Sabine Denzel, Brigitte Mack, Marcus Conrad, Olivier Gires.   

Abstract

Epithelial cell adhesion molecule EpCAM is a transmembrane glycoprotein that is expressed on subsets of normal epithelia, numerous stem- and progenitor-type cells, and most carcinomas and highly overexpressed on cancer-initiating cells. The role of EpCAM in early development, particularly in stem-like cells, has remained unclear. Here, we show that the maintenance of self-renewal in murine embryonic stem (ES) cells depends on the high-level expression of EpCAM. Cultivation of ES cells under differentiation conditions in the absence of leukemia inhibitory factor (LIF) caused down-regulation of EpCAM along with decreased expression of cellular myelocytomatosis oncogene (c-Myc), Sex-determining region Y-Box 2, Octamer 3/4 (Oct3/4), and Stat3. As a consequence ES cells were morphologically differentiated and ceased to proliferate. RNA interference-mediated inhibition of EpCAM expression under self-renewal conditions resulted in quantitatively decreased proliferation, decreased Oct3/4, SSEA-1, and c-Myc expression, and diminished alkaline phosphatase activity. Conversely, exogenous expression of EpCAM partially compensated for the requirement of ES cells for LIF to retain a stem cell phenotype. Thus, murine EpCAM is a transmembrane protein, which is essential but by itself is not sufficient for maintenance of the ES cell phenotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19544432     DOI: 10.1002/stem.97

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  53 in total

Review 1.  EpCAM and its potential role in tumor-initiating cells.

Authors:  Sannia Imrich; Matthias Hachmeister; Olivier Gires
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

2.  Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells.

Authors:  Denis Evseenko; Yuhua Zhu; Katja Schenke-Layland; Jeffrey Kuo; Brooke Latour; Shundi Ge; Jessica Scholes; Gautam Dravid; Xinmin Li; W Robb MacLellan; Gay M Crooks
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

3.  Epithelial-mesenchymal transition and mesenchymal-epithelial transition response during differentiation of growth-plate chondrocytes in endochondral ossification.

Authors:  Shasha Zhou; Yihang Shen; Linlin Wang; Pin Li
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  Defined three-dimensional microenvironments boost induction of pluripotency.

Authors:  Massimiliano Caiazzo; Yuya Okawa; Adrian Ranga; Alessandra Piersigilli; Yoji Tabata; Matthias P Lutolf
Journal:  Nat Mater       Date:  2016-01-11       Impact factor: 43.841

Review 5.  Expression kinetics of hepatic progenitor markers in cellular models of human liver development recapitulating hepatocyte and biliary cell fate commitment.

Authors:  Pooja Chaudhari; Lipeng Tian; Abhijeet Deshmukh; Yoon-Young Jang
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-06

6.  A high-content screen for small-molecule regulators of epithelial cell-adhesion molecule (EpCAM) cleavage yields a robust inhibitor.

Authors:  Jana Ylva Tretter; Kenji Schorpp; Elke Luxenburger; Johannes Trambauer; Harald Steiner; Kamyar Hadian; Olivier Gires; Dierk Niessing
Journal:  J Biol Chem       Date:  2018-04-26       Impact factor: 5.157

7.  cAMP and EPAC Signaling Functionally Replace OCT4 During Induced Pluripotent Stem Cell Reprogramming.

Authors:  Ashley L Fritz; Maroof M Adil; Sunnie R Mao; David V Schaffer
Journal:  Mol Ther       Date:  2015-02-10       Impact factor: 11.454

8.  Cleavage and cell adhesion properties of human epithelial cell adhesion molecule (HEPCAM).

Authors:  Thanos Tsaktanis; Heidi Kremling; Miha Pavšič; Ricarda von Stackelberg; Brigitte Mack; Akio Fukumori; Harald Steiner; Franziska Vielmuth; Volker Spindler; Zhe Huang; Jasmine Jakubowski; Nikolas H Stoecklein; Elke Luxenburger; Kirsten Lauber; Brigita Lenarčič; Olivier Gires
Journal:  J Biol Chem       Date:  2015-08-19       Impact factor: 5.157

9.  Highly efficient elimination of colorectal tumor-initiating cells by an EpCAM/CD3-bispecific antibody engaging human T cells.

Authors:  Ines Herrmann; Patrick A Baeuerle; Matthias Friedrich; Alexander Murr; Susanne Filusch; Dominik Rüttinger; Mariam W Majdoub; Sherven Sharma; Peter Kufer; Tobias Raum; Markus Münz
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

10.  Initial activation of EpCAM cleavage via cell-to-cell contact.

Authors:  Sabine Denzel; Dorothea Maetzel; Brigitte Mack; Carola Eggert; Gabriele Bärr; Olivier Gires
Journal:  BMC Cancer       Date:  2009-11-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.